Perimeter Capital Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-8,709
Closed -$255K 17
2014
Q3
$255K Sell
8,709
-32,632
-79% -$955K 0.43% 58
2014
Q2
$1.61M Buy
41,341
+4,055
+11% +$158K 0.82% 28
2014
Q1
$1.57M Sell
37,286
-6,332
-15% -$266K 0.78% 39
2013
Q4
$1.43M Buy
43,618
+424
+1% +$13.9K 0.7% 54
2013
Q3
$1.17M Buy
+43,194
New +$1.17M 0.22% 149